Seoulin Bioscience
KOSDAQ:A038070
6.230,00
+ ₩130,00 (2,13%)
6.230,00
+₩130,00 (2,13%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩302,08
Earnings Per Share
₩6,27k
Revenue Per Share
22,42%
Gross Margin %
₩54,99 B
Market Cap
₩0,10 B
Long-Term Debt
Earnings Per Share
₩302,08
Revenue Per Share
₩6,27k
Gross Margin %
22,42%
Market Cap
₩54,99 B
Long-Term Debt
₩0,10 B

Financials

Year Year 2025 2024
EPS Earnings Per Share ₩302,08 ₩309,08
Earnings Earnings ₩2,40B ₩2,71B
RPS Revenue Per Share ₩6,27k ₩5,69k
Revenue Revenue ₩49,88B ₩49,88B
OCF Operating Cash Flow ₩0,00M ₩0,00M
FCF Free Cash Flow ₩0,00M ₩0,00M
OM Operating Margin 0,90% 1,26%
GM % Gross Margin % 22,42% 25,14%
FCFS Free Cash Flow Per Share ₩506,16 ₩-536,21
LT Debt Long-Term Debt N/A N/A
Sha. Stocks 7,95M 8,76M
×